# RiVive

NDC: 82954-0100
Generic name: naloxone hydrochloride
Labeler / Manufacturer: Harm Reduction Therapeutics, Inc.
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SPRAY
Routes: NASAL
Marketing started: 20240102

FDA application: NDA217722

## Active ingredients

- NALOXONE HYDROCHLORIDE: 3 mg/.1mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"82954-0100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=82954-0100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1c4f1b9d-1c70-4666-a90e-2f5d2c670d4d